CASExERIE

What CASExERIE does

CASExERIE (Center for Advanced Surgical Exploration, also branded as caseXerie and caseX@erie) is a privately held, Erie, Pennsylvania-based ophthalmic and vitreoretinal surgical innovation hub founded and led by Dr. David RP Almeida. Established in October 2023 and formally launched in 2024, the company operates an "incubator-surgical hybrid facility" that allows medical device companies, entrepreneurs, and practicing surgeons to collaboratively experiment with new surgical technologies and techniques, primarily in the ophthalmic and vitreoretinal sub-specialty.

The company's core offering is the caseX facility — a controlled surgical environment where industry partners and clinicians can test devices and develop techniques together. Layered onto the facility is KTM (Keratome Technique Module), a teaching framework delivered through in-person and virtual hands-on events with live narration by Dr. Almeida. The company markets itself through an event-driven GTM motion, running Case X events in Erie (headquarters, by appointment only), Miami, and Ahmedabad. Dr. Almeida's academic credentials — over 200 peer-reviewed publications, 150+ conference presentations, and 60+ clinical trials as principal investigator — function as the primary credibility mechanism for engaging device industry partners and surgeons.

CASExERIE generates revenue through professional services-style engagements, including facility access, event-based training, and collaborative R&D with medical device companies. Pricing is not publicly disclosed; the company operates on a contact-based inquiry model via [email protected]. No funding rounds, institutional investors, or revenue figures have been disclosed. The firm is founder-led, with Dr. Almeida simultaneously serving as President & CEO of Erie Retina Research, suggesting the two entities share leadership while operating as distinct organizations.

Name

CASExERIE

Legal name

CASExERIE (Center for Advanced Surgical Exploration)

Website

https://casexerie.com

Company type

Private

Founded year

2023

Operating status

Operating

Short description

CASExERIE (Center for Advanced Surgical Exploration) is an Erie, Pennsylvania-based incubator-surgical hybrid facility, founded in 2023, that enables medical device companies and ophthalmic/vitreoretinal surgeons to collaboratively experiment, train, and develop new surgical technologies under Dr. David Almeida's leadership.

Ownership category

akta.pro rank

Product category

Ophthalmic Surgical Research and Training Services

NAICS

Medical Equipment and Supplies Manufacturing (3391)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Ophthalmic surgical innovation
• Vitreoretinal surgery training
• Surgical R&D collaboration
• Medical device incubation
• Clinical trial research

Headquarters

HQ city

Erie

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Surgical Innovation Services: Revenue likely derived from facility access fees, event-based training programs, and collaborative R&D engagements with medical device companies and surgeons. The center positions itself as a hub for surgical research and development under Dr. David Almeida's guidance.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

CASExERIE operates an incubator-surgical hybrid facility focused on ophthalmic and vitreoretinal surgical technology and techniques. It enables industry professionals and practicing surgeons to collaborate on surgical research, experimentation, and product development through hands-on teaching events and KTM (Keratome Technique Module) training.

Product overview

CASExERIE operates as a unified surgical innovation center with a primary focus on ophthalmic and vitreoretinal surgery. The core offering is the caseXerie: Center for Advanced Surgical Exploration, which functions as an incubator-surgical hybrid facility. This center serves as the platform through which the caseX product operates, enabling collaborative experimentation between industry professionals and surgeons. The KTM (Keratome Technique Module) is an add-on teaching module featured in educational events. Under Dr. David Almeida's leadership, the center emphasizes safety, precision, and innovation in surgical research and development.

Differentiator

Problem solved

Functional benefit

Brands

• caseX: The incubator-surgical hybrid facility designed to provide the latest advancements in ophthalmic and vitreoretinal surgical technology and techniques.

Products and services

• caseXerie: Center for Advanced Surgical Exploration
• caseX
• KTM (Keratome Technique Module)

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Unnamed Strategic PartnerscoreStrategic or Co-development PartnerCASExERIE relies on strategic partnerships with surgeons, professionals, researchers and entrepreneurs who are focused on advancing the field of surgery. The center partners with trusted firms that believe in nurturing ideas through incubation and employing precision and expert guidance for advancing ophthalmic and vitreoretinal surgical innovation. Specific partner names are not publicly disclosed on the website.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• GE HealthCare: GE HealthCare is a large medical technology company with ophthalmic imaging and surgical visualization offerings. It is comparable as a broad incumbent in ophthalmic surgical technology that runs surgeon engagement and clinical collaboration programs, competing for industry-surgeon mindshare.
• Carl Zeiss Meditec: Carl Zeiss Meditec is a leading global manufacturer of ophthalmic surgical microscopes, devices, and visualization systems. As a broad incumbent, it overlaps with CASExERIE in ophthalmic surgical technology but operates across a much wider portfolio and has in-house surgeon collaboration and training programs.
• Alcon: Alcon is the largest dedicated ophthalmic surgical and vision care company globally, supplying vitreoretinal instruments, IOLs, and surgical equipment. It is comparable as the dominant industry partner that CASExERIE's incubator model targets, with its own surgeon training and R&D infrastructure.
• Bausch + Lomb: Bausch + Lomb is a major ophthalmic pharmaceutical and surgical device company offering vitreoretinal instruments and surgical equipment. As a broad incumbent, it competes for the same medical device industry partnerships and surgeon training relationships that CASExERIE cultivates.

Direct peers

• Surgical Science: Surgical Science develops virtual reality simulation-based training for surgeons, including minimally invasive and specialty procedures. It is comparable as a surgical training provider serving academic centers and device companies — overlapping with CASExERIE's training and industry-collaboration value proposition, though delivery is digital rather than physical.
• VirtaMed: VirtaMed provides high-fidelity surgical simulation systems for arthroscopy, laparoscopy, and specialty procedures, working closely with medical device companies and societies. It is a direct peer in surgical skills training for industry and surgeon customers, addressing the same 'training + industry collaboration' wedge CASExERIE targets, albeit via simulation hardware.

Regional players

• Dutch Ophthalmic Research Center (DORC): DORC is a specialist manufacturer of vitreoretinal and cataract surgical instruments, headquartered in the Netherlands. It is comparable as a focused vitreoretinal surgical device company that collaborates closely with vitreoretinal surgeons on instrument design — the same constituency CASExERIE serves.

Emerging players

• Vitreq: Vitreq is a niche, innovation-focused ophthalmic surgical device company specializing in vitreoretinal instruments and accessories. It is comparable as a smaller, R&D-driven player in the vitreoretinal device category that relies on surgeon feedback for product development — exactly the type of company CASExERIE's incubator facility is built to serve.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CASExERIE